
We aimed to evaluate disease flare and post vaccination reactions in patients with rheumatic and musculoskeletal diseases following two dose SARS-CoV-2 mRNA vaccination. 1377 patients with RMD who received two dose SARS-CoV-2 mRNA vaccination between 16 December 2020 and April 15, 2021 completed questionnaires detailing local and systemic reactions experienced within 7 days of each vaccine dose , and one month after D2 detailing flare of RMD. Flare was associated with prior SARS-CoV-2 infection , flare in the six months preceding vaccination and use of combination immunomodulatory therapy. No allergic reactions or SARS-CoV-2 diagnoses were reported. Flare of underlying RMD following SARS-CoV-2 vaccination was uncommon.
Like
Save
Share